Supporting Family Carers to People Living With Symptoms of Dementia at Home up to the End of Life
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03666611 |
|
Recruitment Status : Unknown
Verified September 2018 by Sara Yearsley, University of Manchester.
Recruitment status was: Recruiting
First Posted : September 12, 2018
Last Update Posted : September 12, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This is a qualitative study that will seek to gain further understanding of the support needs of family carers to people living with symptoms of dementia up to the end of life.
Family carers are friends, family members or neighbours who provide informal unpaid care to someone with symptoms of dementia. The experience of providing this care may result in family carers developing unmet needs that impact adversely on their total wellbeing. This research is potentially beneficial because little is known about the specific physical, psychological, spiritual and social needs family carers to people dying with dementia may develop.
It is a priority of the UK government and the NHS to better support family carers. The government published guidelines calling on healthcare professionals to assess and address carer needs, but the evidence base for family carers to people with symptoms of dementia is limited. Findings from this study could guide healthcare professionals when they conduct clinical assessments of carer needs.
Each participant to this study will be invited to attend a semi-structured interview at a venue of their choice where they will talk about their experiences of providing care. Participants must have provided informal, unpaid care to a friend, neighbour or family member with symptoms of dementia at home, including within the last twelve months of that person's life. This is a retrospective study so only former family carers will be eligible to participate. Participants must also be over the age of eighteen, be able to communicate in English and have capacity to give informed consent.
This research study is being funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) as part of their Research Capacity in Dementia Care Pilot Programme, which is exploring issues relating to dementia care provision.
| Condition or disease |
|---|
| Family Caregivers |
Show detailed description
| Study Type : | Observational |
| Estimated Enrollment : | 30 participants |
| Observational Model: | Other |
| Time Perspective: | Retrospective |
| Official Title: | Supporting Family Carers to People Living With Symptoms of Dementia at Home up to the End of Life: a Retrospective Qualitative Study Using Principles of Grounded Theory |
| Actual Study Start Date : | October 11, 2017 |
| Estimated Primary Completion Date : | December 31, 2018 |
| Estimated Study Completion Date : | December 31, 2018 |
- To conduct interviews with family carers [ Time Frame: before 31st December, 2018 ]collecting interview data from up to thirty family carers
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Participants may be of any gender, ethnicity or socio-economic grouping.
- Participants must be eighteen years of age or over.
-
Participants must have provided informal, unpaid care or support to a family member, friend or neighbour with dementia during the last twelve months of the life of the person with dementia.
- This care may have been given on a permanent or intermittent basis.
- The person with dementia must have died not less than six months and not more than five years prior to the date of the interview.
- Participants must be able to communicate in English.
- Participants must have capacity to provide informed consent.
- Participants must live, or be able to attend an interview, in North West England, West Yorkshire, The West Midlands or North Wales.
Exclusion Criteria:Individuals will be excluded from participating if:
- They did not give any form of informal unpaid care or support to a person with dementia in the twelve months before that person's death.
- The person they cared for died less than six months or more than five years before the date of the interview.
- They are under eighteen years of age.
- They cannot communicate clearly in English.
- They are unable or unwilling to provide informed consent.
- They do not live, or are unable to attend an interview, in North West England, West Yorkshire, the West Midlands or North Wales.
- The exclusion criteria extend to anyone considered ineligible to approach based on clinical team (Admiral nursing service) concerns about the individual's ability to take part in an interview.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03666611
| Contact: Sara E Yearsley, Ms | 07905203832 | sara.yearsley@manchester.ac.uk |
| United Kingdom | |
| University of Manchester | Recruiting |
| Manchester, United Kingdom, M13 9PL | |
| Contact: Sara E Yearsley, Ms 07905203832 sara.yearsley@manchester.ac.uk | |
| Responsible Party: | Sara Yearsley, PhD research assistant, University of Manchester |
| ClinicalTrials.gov Identifier: | NCT03666611 |
| Other Study ID Numbers: |
sy |
| First Posted: | September 12, 2018 Key Record Dates |
| Last Update Posted: | September 12, 2018 |
| Last Verified: | September 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Dementia End of Life Palliative |
|
Dementia Death Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Neurocognitive Disorders Mental Disorders Pathologic Processes |

